Bridgewater Associates LP raised its position in shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY - Free Report) by 24.4% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 225,523 shares of the medical instruments supplier's stock after buying an additional 44,171 shares during the period. Bridgewater Associates LP owned about 0.11% of DENTSPLY SIRONA worth $4,280,000 as of its most recent filing with the Securities and Exchange Commission.
Other hedge funds also recently modified their holdings of the company. Riverview Trust Co acquired a new stake in shares of DENTSPLY SIRONA during the fourth quarter worth approximately $26,000. MassMutual Private Wealth & Trust FSB increased its holdings in shares of DENTSPLY SIRONA by 648.4% during the fourth quarter. MassMutual Private Wealth & Trust FSB now owns 1,422 shares of the medical instruments supplier's stock worth $27,000 after buying an additional 1,232 shares in the last quarter. UMB Bank n.a. increased its holdings in shares of DENTSPLY SIRONA by 60.8% during the fourth quarter. UMB Bank n.a. now owns 1,492 shares of the medical instruments supplier's stock worth $28,000 after buying an additional 564 shares in the last quarter. Mitsubishi UFJ Asset Management Co. Ltd. increased its holdings in shares of DENTSPLY SIRONA by 700.0% during the fourth quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 1,792 shares of the medical instruments supplier's stock worth $33,000 after buying an additional 1,568 shares in the last quarter. Finally, Signaturefd LLC increased its holdings in shares of DENTSPLY SIRONA by 513.3% during the fourth quarter. Signaturefd LLC now owns 4,428 shares of the medical instruments supplier's stock worth $84,000 after buying an additional 3,706 shares in the last quarter. Institutional investors and hedge funds own 95.70% of the company's stock.
Wall Street Analyst Weigh In
XRAY has been the subject of several recent analyst reports. Mizuho dropped their price objective on shares of DENTSPLY SIRONA from $21.00 to $18.00 and set a "neutral" rating for the company in a report on Thursday, March 13th. Needham & Company LLC reissued a "hold" rating on shares of DENTSPLY SIRONA in a report on Thursday, March 13th. Evercore ISI reissued an "in-line" rating and issued a $20.00 price target on shares of DENTSPLY SIRONA in a report on Tuesday, January 7th. Jefferies Financial Group lowered shares of DENTSPLY SIRONA from a "buy" rating to a "hold" rating and lowered their price target for the company from $30.00 to $20.00 in a report on Thursday, January 23rd. Finally, Robert W. Baird lowered their price target on shares of DENTSPLY SIRONA from $22.00 to $20.00 and set a "neutral" rating for the company in a report on Friday, February 28th. Thirteen investment analysts have rated the stock with a hold rating and two have assigned a buy rating to the company's stock. According to data from MarketBeat, the company currently has an average rating of "Hold" and an average target price of $22.58.
Read Our Latest Stock Report on DENTSPLY SIRONA
Insider Transactions at DENTSPLY SIRONA
In other news, Director Gregory T. Lucier purchased 15,142 shares of DENTSPLY SIRONA stock in a transaction dated Monday, March 3rd. The shares were bought at an average cost of $16.51 per share, with a total value of $249,994.42. Following the completion of the transaction, the director now directly owns 81,971 shares in the company, valued at $1,353,341.21. This trade represents a 22.66 % increase in their position. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Insiders own 0.52% of the company's stock.
DENTSPLY SIRONA Trading Up 2.5 %
XRAY traded up $0.33 during trading on Wednesday, reaching $13.35. 998,706 shares of the company's stock were exchanged, compared to its average volume of 2,905,231. The company's fifty day moving average price is $15.38 and its 200-day moving average price is $18.52. The firm has a market capitalization of $2.66 billion, a PE ratio of -6.45, a P/E/G ratio of 1.80 and a beta of 0.92. DENTSPLY SIRONA Inc. has a fifty-two week low of $12.16 and a fifty-two week high of $31.00. The company has a debt-to-equity ratio of 0.72, a quick ratio of 0.84 and a current ratio of 1.25.
DENTSPLY SIRONA Announces Dividend
The company also recently declared a quarterly dividend, which was paid on Friday, April 11th. Stockholders of record on Friday, March 28th were given a dividend of $0.16 per share. The ex-dividend date of this dividend was Friday, March 28th. This represents a $0.64 dividend on an annualized basis and a dividend yield of 4.79%. DENTSPLY SIRONA's dividend payout ratio is -14.07%.
DENTSPLY SIRONA Company Profile
(
Free Report)
DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.
Further Reading

Before you consider DENTSPLY SIRONA, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and DENTSPLY SIRONA wasn't on the list.
While DENTSPLY SIRONA currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.